Improvement of the clinical applicability of tissue-engineered vascular grafts, as new regenerative therapy for children with congenital cardiovascular malformations

Projektinformationen

LIVAGRAFT

ID Finanzhilfevereinbarung: 626976

Projekt abgeschlossen

Startdatum 1 März 2014

Enddatum 29 Februar 2016

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 199 317,60

EU-Beitrag € 199 317,60

Koordiniert durch

University of Zurich
Switzerland